Why is GE Healthcare Technologies, Inc. ?
1
High Management Efficiency with a high ROCE of 18.55%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 2.11 times
3
Flat results in Jun 25
- OPERATING CASH FLOW(Y) Lowest at USD 1,995 MM
- RAW MATERIAL COST(Y) Grown by 6.56% (YoY)
- OPERATING PROFIT(Q) Lowest at USD 774 MM
4
With ROCE of 18.89%, it has a attractive valuation with a 2.51 Enterprise value to Capital Employed
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -3.27%, its profits have risen by 35.9% ; the PEG ratio of the company is 0.4
5
High Institutional Holdings at 93.07%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -3.27% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to GE Healthcare Technologies, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is GE Healthcare Technologies, Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
GE Healthcare Technologies, Inc.
-0.06%
0.15
36.12%
S&P 500
13.22%
0.61
20.17%
Quality key factors
Factor
Value
Sales Growth (5y)
2.41%
EBIT Growth (5y)
6.92%
EBIT to Interest (avg)
7.73
Debt to EBITDA (avg)
2.11
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
1.10
Tax Ratio
18.50%
Dividend Payout Ratio
2.88%
Pledged Shares
0
Institutional Holding
93.07%
ROCE (avg)
18.55%
ROE (avg)
26.44%
Valuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
3.57
EV to EBIT
13.31
EV to EBITDA
11.16
EV to Capital Employed
2.51
EV to Sales
1.98
PEG Ratio
0.39
Dividend Yield
NA
ROCE (Latest)
18.89%
ROE (Latest)
25.79%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Movement
4What is working for the Company
ROCE(HY)
Highest at 25.6%
DEBT-EQUITY RATIO
(HY)
Lowest at 71.58 %
-8What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD 1,995 MM
RAW MATERIAL COST(Y)
Grown by 6.56% (YoY
OPERATING PROFIT(Q)
Lowest at USD 774 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 15.46 %
PRE-TAX PROFIT(Q)
Lowest at USD 585 MM
NET PROFIT(Q)
Lowest at USD 463.16 MM
Here's what is working for GE Healthcare Technologies, Inc.
Debt-Equity Ratio
Lowest at 71.58 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for GE Healthcare Technologies, Inc.
Operating Cash Flow
Lowest at USD 1,995 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Operating Profit
Lowest at USD 774 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at 15.46 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD 585 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD 463.16 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Raw Material Cost
Grown by 6.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






